Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donaldson, J. O.
Right arrow Articles by Binstock, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donaldson, J. O.
Right arrow Articles by Binstock, M. L.
NEUROLOGY 1981;31:758
© 1981 American Academy of Neurology

Pseudotumor cerebri in an obese woman with Turner syndrome

James O. Donaldson, M.D. and Martin L. Binstock, M.D.

From the Departments of Neurology (Dr. Donaldson) and Medicine (Dr. Binstock), University of Connecticut School of Medicine, Farmington, and the Department of Medicine (Dr. Binstock), St. Francis Hospital, Hartford, CT.

Extraovarian estrogen production was studied in an obese young woman with pathologically confirmed mosaic Turner syndrome and pseudotumor cerebri. Diet plus enough dexamethasone to suppress adrenal steroidogenesis promptly lowered cerebrospinal fluid pressure as well as serum content of androstenedione, estrone, and testosterone. Estrone was detected in cerebrospinal fluid before and after but not during dexamethasone treatment. Extraovarian estrogen probably produces the menstrual irregularities of obese young women with pseudotumor cerebri and may be involved in the pathogenesis of that syndrome.

Address correspondence and reprint requests to Dr. Donaldson, Department of Neurology, University of Connecticut Health Center, Farmington, CT 06032.

Accepted for publication August 21, 1980.




This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. Bell, K. L. Parker, R. D. Swinford, A. R. Hoffman, T. Maneatis, and B. Lippe
Long-Term Safety of Recombinant Human Growth Hormone in Children
J. Clin. Endocrinol. Metab., January 1, 2010; 95(1): 167 - 177.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Bolar, A. R. Hoffman, T. Maneatis, and B. Lippe
Long-Term Safety of Recombinant Human Growth Hormone in Turner Syndrome
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 344 - 351.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. Marcelis and S. D. Silberstein
Idiopathic Intracranial Hypertension Without Papilledema
Arch Neurol, April 1, 1991; 48(4): 392 - 399.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
B. Ireland, J. J. Corbett, and R. B. Wallace
The Search for Causes of Idiopathic Intracranial Hypertension: A Preliminary Case-Control Study
Arch Neurol, March 1, 1990; 47(3): 315 - 320.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
P. S. Sorensen, F. Gjerris, and B. Svenstrup
Endocrine Studies in Patients With Pseudotumor Cerebri: Estrogen Levels in Blood and Cerebrospinal Fluid
Arch Neurol, September 1, 1986; 43(9): 902 - 906.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
J. E. AHLSKOG and B. P. O'NEILL
Pseudotumor Cerebri
Ann Intern Med, August 1, 1982; 97(2): 249 - 256.
[Abstract] [PDF]